Where do Krystal Biotech, Inc.'s ratios come from?

Every ratio is computed from Krystal Biotech, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Profitability
Operating margin	42.8%+10.2pp	41.4%+18.8pp	42.4%+32.3pp	38.8%+53.3pp	32.6%+106pp
Net margin	53.9%+16.7pp	52.6%+21.9pp	53.3%+31.6pp	40.8%-22.9pp	37.2%-22.4pp
EBITDA margin	44.2%+9.8pp	42.9%+18.2pp	43.9%+31.3pp	40.3%+51.5pp	34.4%+103pp
Free cash flow margin	56.9%+16.5pp	48.5%+5.7pp	44.4%+18.1pp	51.6%+62.1pp	40.4%+97.1pp
Returns
Return on equity	19.9%+6.0pp	18.9%+8.6pp	19.7%+13.3pp	15.6%+1.4pp	13.9%+5.0pp
Return on assets	18.2%+5.4pp	17.1%+7.6pp	17.9%+12.0pp	14.3%+1.0pp	12.9%+4.6pp
Return on invested capital	24.3%+7.1pp	24%+12.2pp	24.8%+20.0pp	20.2%+25.6pp	17.2%+34.2pp
Efficiency
Asset turnover	0.3×0.0×	0.3×0.0×	0.3×+0.1×	0.3×+0.1×	0.3×+0.2×
Liquidity
Current ratio	9.5×-0.2×	10×+2.7×	10.1×+2.2×	9.7×+0.2×	9.6×-3.0×
Quick ratio	9.1×-0.2×	9.6×+2.5×	9.7×+2.0×	9.3×0.0×	9.3×-3.2×
Cash ratio	4.7×+0.8×	4.8×+1.4×	4.3×+0.1×	4.1×-0.7×	3.9×-3.7×
Leverage
Debt-to-equity	0×0.0×	0×0.0×	0×0.0×	0×0.0×	0×0.0×
Debt-to-assets	0×0.0×	0×0.0×	0×0.0×	0×0.0×	0×0.0×
Net debt / EBITDA	-2.7×-0.1×	-2.9×+1.8×	-2.3×+9.7×	-2.4×—	-2.6×—
Interest coverage	6.2×+2.5×	5.7×+3.5×	5.5×+2.2×	4.8×+8.3×	3.7×—
Per Share
Book value per share	$41.85+27.0%	$40.72+28.0%	$38.14+28.7%	$34.98+23.6%	$32.96+20.8%
Valuation
Market capitalization	$7.55B+45.4%	$7.15B+58.7%	$5.11B-1.9%	$4.15B-20.1%	$5.19B+3.2%
Enterprise value	$7.06B+44.2%	$6.66B+59.8%	$4.73B-2.3%	$3.81B-21.6%	$4.89B+4.5%
Price / earnings	33.6×-8.3×	34.9×-15.6×	25.7×-73.7×	28.3×-20.8×	41.9×-46.2×
Price / sales	18.1×+2.5×	18.4×+2.9×	13.7×-7.9×	11.6×-19.7×	15.6×-36.9×
Price / book	5.9×+0.6×	5.9×+1.1×	4.5×-1.4×	4×-2.2×	5.3×-1.0×
EV / EBITDA	38.3×-4.5×	39.9×-18.3×	28.9×-130×	26.3×—	42.7×—
EV / sales	16.9×+2.2×	17.1×+2.8×	12.7×-7.4×	10.6×-18.6×	14.7×-34.1×
Free cash flow yield	3.1%+0.6pp	2.6%-0.1pp	3.2%+2.0pp	4.5%+4.8pp	2.6%+3.7pp
Earnings yield	3%+0.6pp	2.9%+0.9pp	3.9%+2.9pp	3.5%+1.5pp	2.4%+1.3pp
PEG ratio	0.4×+0.1×	0.3×+0.2×	0.1×—	0.7×—	0.4×—

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Krystal Biotech, Inc..

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

Where do Krystal Biotech, Inc.'s ratios come from?: Every ratio is computed from Krystal Biotech, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.